Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Naziia Kurmasheva¹, Aida Said^{2

3}, Boaz Wong^{2

4}, Priscilla Kinderman⁵, Xiaoying Han⁶, Anna H F Rahimic¹, Alena Kress^{7

8

9}, Madalina E Carter-Timofte¹, Emilia Holm¹, Demi van der Horst¹, Christoph F Kollmann¹, Zhenlong Liu⁶, Chen Wang⁶, Huy-Dung Hoang^{2

3}, Elina Kovalenko¹, Maria Chrysopoulou¹, Krishna Sundar Twayana¹, Rasmus N Ottosen¹⁰, Esben B Svenningsen¹⁰, Fabio Begnini¹⁰, Anders E Kiib¹⁰, Florian E H Kromm¹⁰, Hauke J Weiss¹¹, Daniele Di Carlo¹², Michela Muscolini¹², Maureen Higgins¹³, Mirte van der Heijden⁵, Rozanne Arulanandam⁴, Angelina Bardoul^{14

15

16}, Tong Tong^{17

18

19}, Attila Ozsvar^{1

18}, Wen-Hsien Hou¹, Vivien R Schack¹, Christian K Holm¹, Yunan Zheng²⁰, Melanie Ruzek²¹, Joanna Kalucka^{1

22}, Laureano de la Vega¹³, Walid A M Elgaher²³, Anders R Korshoej^{17

18

19}, Rongtuan Lin⁶, John Hiscott¹², Thomas B Poulsen¹⁰, Luke A O'Neill¹¹, Dominic G Roy^{14

15

16}, Markus M Rinschen^{1

24

25}, Nadine van Montfoort⁵, Jean-Simon Diallo^{2

4}, Henner F Farin^#^{7

8

26}, Tommy Alain^#^{2

3}, David Olagnier²⁷

Affiliations

¹ Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
² Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
³ Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, K1H 8L1, Canada.
⁴ Ottawa Hospital Research Insitute, Ottawa, ON, K1H 8L6, Canada.
⁵ Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
⁶ Lady Davis Institute, Jewish General Hospital and Department of Medicine, McGill University, Montreal, QC, H3T 1E2, Canada.
⁷ Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany.
⁸ Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany.
⁹ Faculty of Biological Sciences, Goethe University, 60438, Frankfurt am Main, Germany.
¹⁰ Department of Chemistry, Aarhus University, 8000, Aarhus C, Denmark.
¹¹ School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin 2, Ireland.
¹² Pasteur Laboratories, Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, 00161, Italy.
¹³ Jacqui Wood Cancer Centre, Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK.
¹⁴ Cancer Axis, CHUM Research Centre, Montreal, Canada.
¹⁵ Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, University of Montreal, Montreal, Canada.
¹⁶ Institut du Cancer de Montréal, Montreal, QC, Canada.
¹⁷ Department of Neurosurgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.
¹⁸ Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.
¹⁹ DCCC Brain Tumor Center, Copenhagen University Hospital, Copenhagen, Denmark.
²⁰ Small Molecule Therapeutics & Platform Technologies, AbbVie Inc., 1 North Waukegon Road, North Chicago, IL, 60064, USA.
²¹ AbbVie, Bioresearch Center, 100 Research Drive, Worcester, MA, 01608, USA.
²² Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
²³ Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, E8.1, 66123, Saarbrücken, Germany.
²⁴ III. Department of Medicine and Hamburg Center for Kidney Health, Hamburg, Germany.
²⁵ Aarhus Institute of Advanced Studies, Aarhus University, Aarhus, Denmark.
²⁶ German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
²⁷ Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark. olagnier@biomed.au.dk.

^# Contributed equally.

PMID: 39702301
PMCID: PMC11659427
DOI: 10.1038/s41467-024-55044-w

Published Erratum

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Naziia Kurmasheva et al. Nat Commun. 2024.

. 2024 Dec 19;15(1):10698.

doi: 10.1038/s41467-024-55044-w.

Authors

Affiliations

¹ Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
² Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
³ Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, K1H 8L1, Canada.
⁴ Ottawa Hospital Research Insitute, Ottawa, ON, K1H 8L6, Canada.
⁵ Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
⁶ Lady Davis Institute, Jewish General Hospital and Department of Medicine, McGill University, Montreal, QC, H3T 1E2, Canada.
⁷ Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany.
⁸ Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany.
⁹ Faculty of Biological Sciences, Goethe University, 60438, Frankfurt am Main, Germany.
¹⁰ Department of Chemistry, Aarhus University, 8000, Aarhus C, Denmark.
¹¹ School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin 2, Ireland.
¹² Pasteur Laboratories, Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, 00161, Italy.
¹³ Jacqui Wood Cancer Centre, Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK.
¹⁴ Cancer Axis, CHUM Research Centre, Montreal, Canada.
¹⁵ Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, University of Montreal, Montreal, Canada.
¹⁶ Institut du Cancer de Montréal, Montreal, QC, Canada.
¹⁷ Department of Neurosurgery, Aarhus University Hospital, 8200, Aarhus N, Denmark.
¹⁸ Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.
¹⁹ DCCC Brain Tumor Center, Copenhagen University Hospital, Copenhagen, Denmark.
²⁰ Small Molecule Therapeutics & Platform Technologies, AbbVie Inc., 1 North Waukegon Road, North Chicago, IL, 60064, USA.
²¹ AbbVie, Bioresearch Center, 100 Research Drive, Worcester, MA, 01608, USA.
²² Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
²³ Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, E8.1, 66123, Saarbrücken, Germany.
²⁴ III. Department of Medicine and Hamburg Center for Kidney Health, Hamburg, Germany.
²⁵ Aarhus Institute of Advanced Studies, Aarhus University, Aarhus, Denmark.
²⁶ German Cancer Consortium (DKTK), Frankfurt/Mainz partner site and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
²⁷ Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark. olagnier@biomed.au.dk.

^# Contributed equally.

PMID: 39702301
PMCID: PMC11659427
DOI: 10.1038/s41467-024-55044-w

No abstract available

PubMed Disclaimer

Erratum for

Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic AHF, Kress A, Carter-Timofte ME, Holm E, van der Horst D, Kollmann CF, Liu Z, Wang C, Hoang HD, Kovalenko E, Chrysopoulou M, Twayana KS, Ottosen RN, Svenningsen EB, Begnini F, Kiib AE, Kromm FEH, Weiss HJ, Di Carlo D, Muscolini M, Higgins M, van der Heijden M, Arulanandam R, Bardoul A, Tong T, Ozsvar A, Hou WH, Schack VR, Holm CK, Zheng Y, Ruzek M, Kalucka J, de la Vega L, Elgaher WAM, Korshoej AR, Lin R, Hiscott J, Poulsen TB, O'Neill LA, Roy DG, Rinschen MM, van Montfoort N, Diallo JS, Farin HF, Alain T, Olagnier D. Kurmasheva N, et al. Nat Commun. 2024 May 15;15(1):4096. doi: 10.1038/s41467-024-48422-x. Nat Commun. 2024. PMID: 38750019 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Affiliations

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources